Share：
Share this content in WeChat
X
[Chinese][PDF]85342
• Experience Exchang •
Diffusion kurtosis imaging study on changes of brain microstructure and cognitive function in breast cancer survivors with chemotherapy
HAN Yong  YANG Qilin  ZHAO Yuanjing  PAN Changjie 

Cite this article as: Han Y, Yang QL, Zhao YJ, et al. Diffusion kurtosis imaging study on changes of brain microstructure and cognitive function in breast cancer survivors with chemotherapy[J]. Chin J Magn Reson Imaging, 2022, 13(4): 111-114. DOI:10.12015/issn.1674-8034.2022.04.021.


[Abstract] Objective To study changes of brain microstructure and cognitive function after chemotherapy in breast cancer survivors by using voxel-based analysis of diffusion kurtosis imaging (DKI).Materials and Methods A total of 23 breast cancer patients (Stage Ⅰ-Ⅲ), confirmed by pathology, and 26 age-and gender-matched control healthy volunteers were recruited for prospective Neuropsychological assessments and DKI data acquisition. The statistical product and SPSS 25.0 software was performed to evaluate the difference of subjects' general clinical data and mean kurtosis (MK), axial kurtosis (AK), radial kurtosis (RK) value, the correlation between DKI parameters of different brain regions and neuropsychological assessments scores were analyzed.Results There were no statistically significant differences in neuropsychological scores and MK, AK, RK value between the chemotherapy group and the control group before chemotherapy. There were statistically significant differences in Montreal Cognitive Assessment Scale (MoCA), Clock Drawing Test, Auditory Verbal Learning Delay 5 min Test (AVLT2) scores and MK, RK value before and after chemotherapy (P＜0.05). MK value in the genu of corpus callosum, the right posterior cingulate gyrus and the right superior frontal gyrus decreased significantly; RK value in the posterior cingulate gyrus, the right middle frontal gyrus decreased significantly after chemotherapy by false discovery rate (P＜0.05). Correlation analysis shows that MK value of the right posterior cingulate gyrus was positively correlated with AVLT2 results (r=0.548, P=0.007); RK value of the posterior cingulate gyrus was positively correlated with MoCA results (r=0.654, P=0.001) after chemotherapy.Conclusions In the short term, there are dominant region associated with cognitive impairment in breast cancer survivors with chemotherapy. The MK, RK value can be sensitive to changes of brain microstructure, and provide valuable reference for early evaluation of chemotherapy-related cognitive impairment.
[Keywords] breast cancer；diffusion kurtosis imaging；brain damage；chemotherapy-related cognitive impairment

HAN Yong1   YANG Qilin2   ZHAO Yuanjing2   PAN Changjie2*  

1 Department of Radiology, Shanghai Fifth People's Hospital of Fudan University, Shanghai 201100, China

2 Department of Radiology, Changzhou No. 2 People's Hospital, Changzhou 213100, China

Pan CJ, E-mail: pcj424815@sina.com

Conflicts of interest   None.

Received  2021-09-17
Accepted  2022-03-25
DOI: 10.12015/issn.1674-8034.2022.04.021
Cite this article as: Han Y, Yang QL, Zhao YJ, et al. Diffusion kurtosis imaging study on changes of brain microstructure and cognitive function in breast cancer survivors with chemotherapy[J]. Chin J Magn Reson Imaging, 2022, 13(4): 111-114. DOI:10.12015/issn.1674-8034.2022.04.021.

[1]
Zou XN, Jia MM, Wang X, et al. Interpretation of the world cancer report 2020[J]. Chin J Clin Thorac Cardiovasc Surg, 2021, 28(1): 11-18. DOI: 10.7507/1007-4848.202010033.
[2]
Hermelink K. Chemotherapy and cognitive function in breast cancer patients: the so-called chemo brain[J]. J Natl Cancer Inst Monogr, 2015, (51): 67-69. DOI: 10.1093/jncimonographs/lgv009.
[3]
Park JH, Jung YS, Jung YM, et al. The role of depression in the relationship between cognitive decline and quality of life among breast cancer patients[J]. Support Care Cancer, 2019, 27(7): 2707-2714. DOI: 10.1007/s00520-018-4546-x.
[4]
Cimprich B, Reuter-Lorenz P, Nelson J, et al. Prechemotherapy alterations in brain function in women with breast cancer[J]. J Clin Exp Neuropsychol, 2010, 32(3): 324-331. DOI: 10.1080/13803390903032537.
[5]
Sun XR, Wang XC, Zhang H, et al. Research progress of diffusion magnetic resonance imaging in mild cognitive impairment[J]. Chin J Magn Reson Imaging, 2021, 12(1): 70-72, 84. DOI: 10.12015/issn.1674-8034.2021.01.015.
[6]
Nie HY, Chen J, Ao YW, et al. A voxel-based diffusion kurtosis imaging study of whole-brain in alcohol dependent patients[J]. Chin J Radiol, 2018, 52(3): 161-165. DOI: 10.3760/cma.j.issn.1005-1201.2018.03.001.
[7]
Feng Y, Zhang XD, Zheng G, et al. Chemotherapy-induced brain changes in breast cancer survivors: evaluation with multimodality magnetic resonance imaging[J]. Brain Imaging Behav, 2019, 13(6): 1799-1814. DOI: 10.1007/s11682-019-00074-y.
[8]
Deprez S, Amant F, Smeets A, et al. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning[J]. J Clin Oncol, 2012, 30(3): 274-281. DOI: 10.1200/JCO.2011.36.8571.
[9]
Paquet L, Collins B, Song XN, et al. A pilot study of prospective memory functioning in early breast cancer survivors[J]. Breast, 2013, 22(4): 455-461. DOI: 10.1016/j.breast.2013.04.002.
[10]
Cascella M, di Napoli R, Carbone D, et al. Chemotherapy-related cognitive impairment: mechanisms, clinical features and research perspectives[J]. Recenti Prog Med, 2018, 109(11): 523-530. DOI: 10.1701/3031.30289.
[11]
Chen VC, Lin KY, Tsai YH, et al. Connectome analysis of brain functional network alterations in breast cancer survivors with and without chemotherapy[J]. PLoS One, 2020, 15(5): e0232548. DOI: 10.1371/journal.pone.0232548.
[12]
Vincent JL, Kahn I, Snyder AZ, et al. Evidence for a frontoparietal control system revealed by intrinsic functional connectivity[J]. J Neurophysiol, 2008, 100(6): 3328-3342. DOI: 10.1152/jn.90355.2008.
[13]
McDonald BC, Conroy SK, Ahles TA, et al. Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study[J]. Breast Cancer Res Treat, 2010, 123(3): 819-828. DOI: 10.1007/s10549-010-1088-4.
[14]
Mo CQ, Lin HL, Fu FM, et al. Chemotherapy-induced changes of cerebral activity in resting-state functional magnetic resonance imaging and cerebral white matter in diffusion tensor imaging[J]. Oncotarget, 2017, 8(46): 81273-81284. DOI: 10.18632/oncotarget.18111.
[15]
Winocur G, Henkelman M, Wojtowicz JM, et al. The effects of chemotherapy on cognitive function in a mouse model: a prospective study[J]. Clin Cancer Res, 2012, 18(11): 3112-3121. DOI: 10.1158/1078-0432.CCR-12-0060.
[16]
Mounier NM, Abdel-Maged AE, Wahdan SA, et al. Chemotherapy-induced cognitive impairment (CICI): an overview of etiology and pathogenesis[J]. Life Sci, 2020, 258: 118071. DOI: 10.1016/j.lfs.2020.118071.
[17]
Liu W, Song C, Chen HH, et al. DTI observation on changes of brain white matter microstructure and cognitive function in breast cancer patients undergoing chemotherapy[J]. Chin J Med Imaging Technol, 2019, 35(4): 516-520. DOI: 10.13929/j.1003-3289.201810089.
[18]
Wang Y, Shen J, Lin L, et al. Brain metabolites of the posterior cingulate cortex in type 2 diabetes mellitus with cognitive dysfunction: a 1H-MRS study[J]. J Pract Radiol, 2018, 34(10): 1485-1490. DOI: 10.3969/j.issn.1002-1671.2018.10.001.
[19]
Tong TS, Lu H, Zong J, et al. Chemotherapy-related cognitive impairment in patients with breast cancer based on MRS and DTI analysis[J]. Breast Cancer, 2020, 27(5): 893-902. DOI: 10.1007/s12282-020-01094-z.
[20]
Cheng HD, Li W, Gong L, et al. Altered resting-state hippocampal functional networks associated with chemotherapy-induced prospective memory impairment in breast cancer survivors[J]. Sci Rep, 2017, 7: 45135. DOI: 10.1038/srep45135.
[21]
Hu RL, Xiao JP, Li Q, et al. The study of diffusion tensor imaging and serum α-synuclein onin evaluating the Parkinson's disease patients with cognitive impairment[J]. J Apoplexy Nerv Dis, 2020, 37(4): 322-325. DOI: 10.19845/j.cnki.zfysjjbzz.2020.0331.
[22]
Han RL, Yang YM, Dietrich J, et al. Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system[J]. J Biol, 2008, 7(4): 12. DOI: 10.1186/jbiol69.

PREV Clinical application of cardiac magnetic resonance feature tracking technique in rheumatic mitral stenosis and concurrent atrial fibrillation
NEXT The value of IDEAL-IQ in differential diagnosis of AFP-negative hepatocellular carcinoma and focal nodular hyperplasia
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn